Myopia Profile, the international clinical myopia management information centre for eyecare professionals (ECPs), has announced several developments for September’s inaugural Myopia Action Month. The
In 2022, Maddy Scavone, Melbourne paediatric orthoptist and founder of amblyopic patches company Speckles, told NZ Optics, “Really, a lot of kids’ sunglasses are toys unless they have good UV
Contact lens educators from Colombia, India and Jordan received this year’s prestigious awards from the International Association of Contact Lens Educators (IACLE) for their outstanding contributions
Phase 2b trials of Orasis Pharmaceuticals’ presbyopia treatment, CSF-1 (0.4% pilocarpine HCl) showed 80% patients achieved a two-line improvement in near vision, comparable to achieving 20/40 or
Aiming to establish a trans-Tasman network to collaboratively devise new strategies to benefit patients and the eye health sector, Specsavers held its first cross-sector meeting for patient support bodies from Australia and New Zealand.
Hoya Vision Care has launched a Miyosmart sun range of photochromic or polarised lenses to provide sun protection while slowing myopia progression in children. Miyosmart Chameleon (photochromic) and
The Australian Health Practitioner Regulation Agency (Ahpra) is calling for feedback from medical professionals as it reviews the national standard that sets the bar for criminal history for its
US researchers found an anti-IL-6 antibody optimised for intravitreal injection (RG6179, Roche) resulted in improved vision and retinal thickness and was well tolerated in uveitic macular oedema (UMO)
US researchers have demonstrated retinal vessel skeleton density (VSD) showed significant association with at least some measures of cognition, even in cognitively intact subjects at risk of vascular
A Macquarie University team has discovered that damaging a key protein can weaken Acinetobacter baumannii – an antibiotic-resistant bacterium able to survive for a year on dry hospital
Melbourne-based muPharma has developed an ultrasound-based, non-invasive device to deliver drugs which would ordinarily require injection or other highly invasive delivery methods. The device’s
Melbourne-based muPharma has developed an ultrasound-based, non-invasive device to deliver drugs which would ordinarily require injection or other highly invasive delivery methods. The device’s
